Your browser doesn't support javascript.
loading
Development of aptamer-based inhibitors for CRISPR/Cas system.
Zhao, Jing; Inomata, Rika; Kato, Yoshio; Miyagishi, Makoto.
Affiliation
  • Zhao J; Molecular Composite Physiology Research Group, Health and Medical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 1-1-1 Higashi, Tsukuba Science City 305-8566, Japan.
  • Inomata R; Department of Plant Pathology, Nanjing Agricultural University, Nanjing 210095, China.
  • Kato Y; Molecular Composite Physiology Research Group, Health and Medical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 1-1-1 Higashi, Tsukuba Science City 305-8566, Japan.
  • Miyagishi M; Program in Life Science Innovation, School of Integrative and Global Majors, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8577, Japan.
Nucleic Acids Res ; 49(3): 1330-1344, 2021 02 22.
Article in En | MEDLINE | ID: mdl-33123724
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aptamers, Nucleotide / CRISPR-Cas Systems / Gene Editing / CRISPR-Associated Protein 9 Limits: Humans Language: En Journal: Nucleic Acids Res Year: 2021 Document type: Article Affiliation country: Japan Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aptamers, Nucleotide / CRISPR-Cas Systems / Gene Editing / CRISPR-Associated Protein 9 Limits: Humans Language: En Journal: Nucleic Acids Res Year: 2021 Document type: Article Affiliation country: Japan Country of publication: United kingdom